More specifically, therapeutic modulation of FN1, TPT1, RTN4, and FSTL1, for which knockdown has been shown to result in reduced cell proliferation and migration in cancer cells (57, 62, 69, 70), may represent new potential therapeutic avenues for pterygia as well. The gene discussed is RTN4; the disease is cancer.